PRC2 Inhibitors Overcome Glucocorticoid Resistance Driven by NSD2 Mutation in Pediatric Acute Lymphoblastic Leukemia-Reference-Cited by-同舟云学术

PRC2 Inhibitors Overcome Glucocorticoid Resistance Driven by NSD2 Mutation in Pediatric Acute Lymphoblastic Leukemia

Published:2021-08-20 Issue:1 Volume:12 Page:186-203
ISSN:2159-8274
Container-title:Cancer Discovery
language:en
Short-container-title:Cancer Discov

Author:

Li Jianping,Hlavka-Zhang Julia^ORCID,Shrimp Jonathan H.^ORCID,Piper Crissandra,Dupéré-Richér Daphne,Roth Jacob S.^ORCID,Jing Duohui^ORCID,Casellas Román Heidi L.,Troche Catalina,Swaroop Alok^ORCID,Kulis Marta,Oyer Jon A.,Will Christine M.,Shen Min,Riva Alberto^ORCID,Bennett Richard L.,Ferrando Adolfo A.,Hall Matthew D.^ORCID,Lock Richard B.,Licht Jonathan D.^ORCID

Funder

Leukemia and Lymphoma Society Specialized Center of Excellence Grant

Leukemia and Lymphoma Society Special Fellow Grants

Rally Foundation for Childhood Cancer ResearchBear Necessities Pediatric Cancer Foundation

Cancer Australia and The Kids' Cancer Project Grant

National Health and Medical Research Council of Australia NHMRC Fellowships

Cancer Institute NSW Early Career Fellowship

Publisher

American Association for Cancer Research (AACR)

Subject

Oncology

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DNMT3A loss drives a HIF-1-dependent synthetic lethality to HDAC6 inhibition in non-small cell lung cancer;Acta Pharmaceutica Sinica B;2024-09

2. Clonal evolution of the 3D chromatin landscape in patients with relapsed pediatric B-cell acute lymphoblastic leukemia;Nature Communications;2024-08-28

3. Recent advances in targeting histone H3 lysine 36 methyltransferases for cancer therapy;European Journal of Medicinal Chemistry;2024-08

4. Recruitment of FBXO22 for targeted degradation of NSD2;Nature Chemical Biology;2024-07-04

5. Epithelial NSD2 maintains FMOs-mediated taurine biosynthesis to prevent intestinal barrier disruption;2024-05-14